We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Resources
Form 483s Database
FDA Approved Drugs
eCFR and Guidances
White Papers
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Advertising
Sign In
Create Account
Sign Out
My Account
Home
» Cardiac Science Cited Over Purchasing Data
Cardiac Science Cited Over Purchasing Data
March 7, 2017
Devices
Inspections and Audits
The FDA flagged numerous compliance issues following an inspection of Cardiac Science’s Deerfield, Wis., facility.
To View This Article:
Login
Email
Password
Register
Remember Me
Forgot your password?
Subscribe To The GMP Letter
Buy This Article Now
Add this article to your cart for $157.00
Upcoming Events
06
Jun
Gene & Cell Therapy Regulation: Comparability and Other New Developments
07
Jun
Developing World-Class SOPs: Optimizing Quality and Compliance
08
Jun
Implementing ICH E8 R1 Recommendations Increases Site and Participant Relationship Scoring Measures
13
Jun
Winners Only: 3 Steps to Compete in Digital Quality
14
Jun
Pharmaceutical Quality Risk Management and ICH Q9(R1): Navigating the Global Intersection of Principle and Regulation
20
Jun
What’s CSA? And how can it streamline your GxP System Verification?
Featured Products
FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485
Selecting and Implementing Electronic Document Management Systems in the EU
Featured Stories
Blue Earth’s Radiohyrid PET Imaging Agent for Prostate Cancer Gets FDA Approval
Kane Biotech Gets 510(k) Nod for coactiv+ Antimicrobial Wound Gel
Lexicon’s Once-a-Day Tablet to Reduce Risks of Heart Failure Gets FDA Approval
FDA Clears Think Surgical’s Hand-Held Robot for Knee Replacement
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
